HIV Pre-Exposure Prophylaxis: Past, Present and Future

Roy M. Gulick, MD, MPH
Professor of Medicine
Chief, Division of Infectious Diseases
Weill Medical College of Cornell University, New York, NY



VIDEOTop of page

Learning Objectives: Top of page

At the completion of this educational session, learners will:
  1. Discuss the latest data on pre-exposure prophylaxis (PrEP).
  2. Know current U.S. recommendations on PrEP.
  3. Learn about newer drugs for PrEP.

About the Presenter: Top of page

Roy M. (Trip) Gulick is Professor of Medicine and Chief of the Division of Infectious Diseases at Weill Medical College of Cornell University in New York City. He currently serves as Principal Investigator of the Cornell HIV Clinical Trials Unit of the AIDS Clinical Trials Group (ACTG), sponsored by the National Institutes of Health. He also serves as a Board Member of the International AIDS Society-USA, and as a member of the Panel on Clinical Practices for Treatment of HIV Infection of the U.S. Department of Health and Human Services.

You must be logged in to post a comment. Login | Register